The report provides a detailed analysis essential for establishing a Moxidectin production plant. It encompasses all critical aspects necessary for Moxidectin production, including the cost of Moxidectin production, Moxidectin plant cost, Moxidectin production costs, and the overall Moxidectin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Moxidectin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Moxidectin is an FDA-approved semi-synthetic drug widely known for its antiparasitic activity. It is widely used for the treatment and prevention of gastrointestinal nematodes, heartworm, and lungworms in various animals due to its potential activity against nematodes, insects, and acari. Moreover, it also finds its application as an anthelmintic for the treatment of a broad range of parasitic infections. Additionally, it is also employed in the treatment of generalized demodicosis and other skin conditions in animals.
The market for Moxidectin is largely driven by its applications for the treatment of parasitic infections in animals due to its potent antiparasitic activity, which significantly boosts its demand in the veterinary medicine industry. Moreover, its employment as a topical treatment for various skin infections, such as onchocerciasis and generalized demodicosis in animals, such as cattle, dogs, and cats, further accentuates its demand in the animal health industry. Furthermore, industrial Moxidectin procurement is notably influenced due to several factors, including the availability of raw materials (Streptomyces cyanogriseus, etc.), cost and pricing, maintaining quality standards, optimized distribution and logistics, new advances in science or technology, etc.
Raw Material for Moxidectin Production
According to the Moxidectin production plant project report, the major raw material for Moxidectin production includes Streptomyces cyanogriseus.
Production Process of Moxidectin
The extensive Moxidectin production cost report consists of the following industrial production process:
- Production via Fermentation: In this method, Moxidectin is synthesized through a combination of fermentation and chemical production processes. This method of production is initiated by the process of fermentation of Streptomyces cyanogriseus to produce Moxidectin as the product. The process involves the use of cultures of Streptomyces cyanogriseus that undergo fermentation under controlled conditions to synthesize Nemadectin. Further, the obtained nemadectin is subjected to methyloximation, which results in the formation of Moxidectin as the final product.
Moxidectin is a 16-member pentacyclic lactone that belongs to the class of Milbemycin. It is an FDA-approved drug and is classified as a second-generation macrocyclic lactone. Moreover, the molecular formula of the compound is C37H53NO8, and its molecular weight is 639.8 g/mol. The melting point and the boiling point of the compound are 132 °C and 790.0°C, respectively. Additionally, the density of the compound is 1.23 g/cm3, and it is light-sensitive. It appears in the form of white solid that is generally stored as sealed in a freezer at a temperature under -20°C. Its value of dissociation constant (pka) is 12.46.
